Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR3 | P51677 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | GBA1 | P04062 | 1/20 | 0.42 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.40 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.40 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14632774 | 0.82 | CCR3 (0.42) | CCR3ALDH1A1GBA1MEN1GAA | |
| SCHEMBL11404840 | 0.82 | CARM1 (0.42) | CCR3ALDH1A1GBA1TMEM97SIGMAR1 | |
| SCHEMBL11524171 | 0.79 | CCR3 (0.47) | CCR3ALDH1A1GBA1MEN1GAA | |
| SCHEMBL14632360 | 0.76 | DDB1 (0.41) | ALDH1A1MEN1GAAKMT2AHSD17B10 | |
| SCHEMBL6935026 | 0.75 | NPSR1 (0.43) | ALDH1A1GRIN2BMEN1KMT2A | |
| SCHEMBL1150161 | 0.75 | CTSL (0.46) | ALDH1A1KMT2ATMEM97SIGMAR1CARM1 | |
| SCHEMBL6933594 | 0.75 | KDM4E (0.48) | ALDH1A1GRIN2BMEN1GAAKMT2A | |
| SCHEMBL10187536 | 0.74 | GBA1 (0.44) | CCR3ALDH1A1GBA1TMEM97SIGMAR1 | |
| SCHEMBL1558534 | 0.74 | GBA1 (0.48) | CCR3ALDH1A1GBA1MEN1GAA | |
| SCHEMBL11529607 | 0.73 | CCR3 (0.41) | CCR3ALDH1A1MEN1GAAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9994726-B2 | Laminate, method for producing same, and gas barrier material | TOPPAN PRINTING CO., LTD. (JP) | 2018-06-12 | — | — | US | disclosed |
| US-20180131005-A1 | CARBON FIBER COMPOSITE, METHOD FOR PRODUCING SAME, CATALYST SUPPORT AND POLYMER ELECTROLYTE FUEL CELL | TOPPAN PRINTING CO., LTD. (JP) | 2018-05-10 | — | — | US | disclosed |
| US-9950846-B2 | Laminate, manufacturing method and shaped container | TOPPAN PRINTING CO., LTD. (JP) | 2018-04-24 | — | — | US | disclosed |
| EP-2417149-B1 | METHODS FOR THE PREPARATION OF DROSPIRENONE | EVESTRA INC (US) | 2016-09-14 | — | — | EP | disclosed |
| US-20140356767-A1 | CARBON FIBER COMPOSITE, METHOD FOR PRODUCING SAME, CATALYST SUPPORT AND POLYMER ELECTROLYTE FUEL CELL | TOPPAN PRINTING CO., LTD. (JP) | 2014-12-04 | — | — | US | disclosed |
| US-20140017430-A1 | LAMINATE, MANUFACTURING METHOD AND SHAPED CONTAINER | TOPPAN PRINTING CO., LTD. (JP) | 2014-01-16 | — | — | US | disclosed |
| EP-2554589-A1 | FILM-FORMING COMPOSITION AND SHEET | Toppan Printing Co., Ltd. (JP) | 2013-02-06 | — | — | EP | disclosed |
| US-20130022827-A1 | Composition for Forming Film and Film Sheet | TOPPAN PRINTING CO., LTD. (JP) | 2013-01-24 | — | — | US | disclosed |
| US-8334375-B2 | Methods for the preparation of drospirenone | EVESTRA, INC. (US) | 2012-12-18 | — | — | US | disclosed |
| EP-2417149-A1 | METHODS FOR THE PREPARATION OF DROSPIRENONE | Evestra, Inc. (US) | 2012-02-15 | — | — | EP | disclosed |
| WO-2010118023-A1 | METHODS FOR THE PREPARATION OF DROSPIRENONE | EVESTRA, INC. (US) | 2010-10-14 | — | — | WO | disclosed |
| US-20100261896-A1 | METHODS FOR THE PREPARATION OF DROSPIRENONE | EVESTRA, INC. | 2010-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100261896-A1 | METHODS FOR THE PREPARATION OF DROSPIRENONE | CYP17A1, CYP11A1, DHCR7 | CCR3 4198/4885ALDH1A1 2310/4885GBA1 1696/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.